R&D Systems™ Human IL-22BP Fc Chimera Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Manufacturer: R&D Systems™ 1087BP025
DescriptionThe Recombinant Human IL-22BP Fc Chimera Protein is derived from NS0. The Recombinant Human IL-22BP Fc Chimera Protein has been validated for the following applications: Bioactivity.
This product(s) resides on a Fisher Scientific GSA or VA contract. If you are viewing this page as a nonregistered user, the price(s) displayed is List Price. To view your GSA or VA contract pricing, log in using your account number, or become a registered user by contacting one of our Customer Service teams. You can also view your contract price by searching for this item(s) on GSA Advantage. To place an order, contact Fisher Scientific Customer Service.
|IL-22BP Fc Chimera|
|Mouse myeloma cell line,NS0-derived human IL-22BP protein, (N-terminus) Human IL-22BP (Thr22-Pro231) Accession &Num; NP_851826 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)|
|Lyophilized from a 0.2μm filtered solution in PBS.|
|51.3 kDa (monomer)|
|90%, by SDS-PAGE under reducing conditions and visualized by silver stain.|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok